|
⚲
|
| Keyboard |
| Lux Venture Partners IV LLC | |
|---|---|
| Firm | Lux Capital Management LLC |
| Address | c/o Lux Capital Management 295 Madison Avenue, 24th Floor New York, NY 10017 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Lux Capital Management LLC | |||||
| Lux Ventures IV LP | 021-233850 | Promoter | of 350.0 M |
355.4 M | |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Aeva Technologies Inc AEVA
Common Stock
|
2022-08-05 | Other | 7,346,159 | $0.00 | |
|
Science 37 Holdings Inc SNCE
Common Stock
|
2022-04-04 | Other | 2,914,667 | $0.00 | |
|
Recursion Pharmaceuticals Inc RXRX
Class A common stock
|
2021-12-07 | Other | 4,265,576 | $0.00 | |
|
Latch Inc LTCH
Common Stock
|
2021-09-28 | Other | 2,409,489 | $0.00 | |
|
Latch Inc LTCH
Common Stock
|
2021-09-28 | Other | 1,358,164 | $0.00 | |
|
Aeva Technologies Inc AEVA
Common Stock
|
2021-09-08 | Other | 7,346,159 | $0.00 | |
|
Recursion Pharmaceuticals Inc RXRX
Class A Common Stock
|
2021-04-20 | Conversion | 17,187,095 | ||
|
Recursion Pharmaceuticals Inc RXRX
Common Stock
|
2021-04-20 | Conversion | 17,187,095 | ||
|
Recursion Pharmaceuticals Inc RXRX
Common Stock
|
2021-04-20 | Conversion | 17,174,594 | ||
|
Recursion Pharmaceuticals Inc RXRX
Series C Preferred Stock · derivative
|
2021-04-20 | Conversion | 1,825,883 | $0.00 | |
|
Recursion Pharmaceuticals Inc RXRX
Series D Preferred Stock · derivative
|
2021-04-20 | Conversion | 1,490,783 | $0.00 | |
|
Recursion Pharmaceuticals Inc RXRX
Series B Preferred Stock · derivative
|
2021-04-20 | Conversion | 3,578,653 | $0.00 | |
|
Recursion Pharmaceuticals Inc RXRX
Series A Preferred Stock · derivative
|
2021-04-20 | Conversion | 10,279,275 | $0.00 | |
|
Recursion Pharmaceuticals Inc RXRX
Class A Common Stock
|
2021-04-16 | Buy | 100,000 | $18.00 | 1,800,000 |